We are live on ! Find out more
PAS

Point72 Asia (Singapore) Portfolio holdings

AUM $646M
1-Year Est. Return 35.24%
This Fund
S&P 500
This Quarter Est. Return
+6.29%
1 Year Est. Return
+35.24%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$532M
AUM Growth
+$52M
Cap. Flow
+$25.2M
Cap. Flow %
4.73%
Top 10 Hldgs %
35.77%
Holding
1,414
New
404
Increased
239
Reduced
267
Closed
497

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$22.5M
2
AVGO icon
Broadcom
AVGO
+$19.5M
3
RTX icon
RTX Corp
RTX
+$13.2M
4
ICLR icon
Icon
ICLR
+$10.9M
5
COP icon
ConocoPhillips
COP
+$10.3M

Sector Composition

Rank Sector Weight
1 Technology 25.5%
2 Communication Services 16.83%
3 Healthcare 13.7%
4 Financials 12.94%
5 Industrials 10.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LKQ icon
301
LKQ Corp
LKQ
$6.22B
$276K 0.05%
+6,915
New +$285K
CLDT
302
Chatham Lodging
CLDT
$580M
$275K 0.05%
32,270
-42,631
-57% -$361K
OSUR icon
303
OraSure Technologies
OSUR
$275M
$274K 0.05%
64,132
-25,582
-29% -$110K
TXG icon
304
10x Genomics
TXG
$7.44B
$273K 0.05%
+12,088
New +$250K
LNT icon
305
Alliant Energy
LNT
$17.7B
$272K 0.05%
+4,478
New +$254K
AMLX icon
306
Amylyx Pharmaceuticals
AMLX
$2.53B
$271K 0.05%
83,563
+1,521
+2% +$3.42K
OFIX icon
307
Orthofix Medical
OFIX
$418M
$270K 0.05%
+17,295
New +$277K
KURA icon
308
Kura Oncology
KURA
$874M
$268K 0.05%
+13,720
New +$278K
IOSP icon
309
Innospec
IOSP
$2.29B
$267K 0.05%
2,364
+1,420
+150% +$165K
AKRO
310
DELISTED
Akero Therapeutics
AKRO
$265K 0.05%
+9,230
New +$241K
DNA icon
311
Ginkgo Bioworks
DNA
$500M
$263K 0.05%
32,319
+32,210
+29,550% +$323K
SPB icon
312
Spectrum Brands
SPB
$2.02B
$263K 0.05%
2,767
-397
-13% -$35.1K
MTDR icon
313
Matador Resources
MTDR
$6.49B
$263K 0.05%
+5,325
New +$300K
NFBK
314
DELISTED
Northfield Bancorp
NFBK
$263K 0.05%
22,632
-43,489
-66% -$499K
MTZ icon
315
MasTec
MTZ
$21.5B
$262K 0.05%
2,129
+1,329
+166% +$145K
VRSN icon
316
VeriSign
VRSN
$26.5B
$262K 0.05%
+1,377
New +$248K
KALU icon
317
Kaiser Aluminum
KALU
$3.06B
$261K 0.05%
3,597
+605
+20% +$46.5K
SFBS
318
ServisFirst Bancshares
SFBS
$4.84B
$260K 0.05%
3,231
+1,901
+143% +$145K
LBTYK icon
319
Liberty Global Class C
LBTYK
$3.41B
$260K 0.05%
+12,016
New +$237K
CIEN icon
320
Ciena
CIEN
$54.9B
$259K 0.05%
+4,206
New +$222K
AIN icon
321
Albany International
AIN
$1.73B
$258K 0.05%
2,905
+1,906
+191% +$168K
MDU icon
322
MDU Resources
MDU
$4.29B
$256K 0.05%
16,846
+5,090
+43% +$72.5K
RRX icon
323
Regal Rexnord
RRX
$11.5B
$255K 0.05%
+1,537
New +$237K
GAP
324
The Gap Inc
GAP
$7.74B
$248K 0.05%
11,254
+2,629
+30% +$58.4K
ITRI icon
325
Itron
ITRI
$4.49B
$246K 0.05%
2,305
+442
+24% +$44.7K

Similar funds

Point72 Asia (Singapore)'s Q3 2024 Portfolio in Review

As of Q3 2024, Point72 Asia (Singapore) held 1,414 positions worth $532M, up 11% from $480M the previous quarter. Its ten largest holdings account for 36% of the portfolio.

Point72 Asia (Singapore) deployed $25.2M of net new capital in Q3 2024, opening 404 new positions and adding to 239 existing holdings. Its largest new stake was Meta Platforms (Facebook): 45,704 shares worth $26.2M.

By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 24% a quarter earlier, followed by Communication Services and Healthcare.

On the sell side, the largest reduction was RTX Corp, an estimated $13.2M trimmed.

  • Point72 Asia (Singapore)'s largest Q3 2024 buy was Meta Platforms (Facebook): 45,704 shares worth $26.2M.
  • Point72 Asia (Singapore) added most to NVIDIA in Q3 2024, an estimated $33.1M increase.
  • Point72 Asia (Singapore)'s biggest Q3 2024 reduction was RTX Corp, cutting an estimated $13.2M.
  • Point72 Asia (Singapore) fully exited Apple in Q3 2024, selling an estimated $22.5M.
  • Point72 Asia (Singapore)'s ten largest holdings make up 36% of its $532M portfolio in Q3 2024.
  • Point72 Asia (Singapore) opened 404 new positions and closed 497 in Q3 2024.
  • Point72 Asia (Singapore)'s portfolio value rose 11% quarter-over-quarter to $532M.

Based on Point72 Asia (Singapore)'s 13F filing for Q3 2024, filed 14 Nov 2024.